Monoclonal Antibodies, designed to mimic the body’s natural immune response, are
available as a treatment for COVID-19 for patients at high risk of progression to severe
disease.
There are several approved treatments for coronavirus disease 2019 (COVID-19) in
hospitalized patients but few for patients who are not sick enough to be hospitalized.
Monoclonal antibodies are a new treatment for outpatients with COVID-19 who are at
risk of progression to severe disease.
For more info check it out right here.